• Refine your search:
  • 
    Keyword:
    
    • Aged (2)
    • Cardiovascular Diseases / etiology (2)
    • Cholesterol / blood (2)
    • Combination (2)
    • Diabetes Mellitus (2)
    • Double-Blind Method (2)
    • Drug Therapy (2)
    • Fatty Acids (2)
    • Female (2)
    • Follow-Up Studies (2)
    •   more
  • 
    Creator / Publisher:
    
    • Panda, M (4)
    • Alladi, S (3)
    • Balasubramanian, Anusha (3)
    • Marinis, T (3)
    • Tsimpli, Ianthi (3)
    • Vogelzang, Margreet (3)
    • Aarsland, T. (2)
    • Abbas, R. (2)
    • Abbott, C. (2)
    • Abdallah, A. (2)
    •   more
  • 
    Year
  • 
    Medium
  • 
    Type
  • 
    BLLDB-Access

Search in the Catalogues and Directories

All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year AND OR AND NOT All fields Title Creator / Publisher Keyword Year Sort by creator [A → Z]' creator [Z → A]' publishing year ↑ (asc)' publishing year ↓ (desc)' title [A → Z]' title [Z → A]' Simple Search Hits 1 – 6 of 6 1 How Cognitive Abilities May Support Children’s Bilingual Literacy Development in a Multilingual Society ... Vogelzang, Margreet; Tsimpli, IM; Panda, M. - : Apollo - University of Cambridge Repository, 2022 BASE Show details 2 Linguistic diversity, multilingualism, and cognitive skills: A study of disadvantaged children in India ... Tsimpli, Ianthi; Vogelzang, Margreet; Balasubramanian, Anusha. - : Apollo - University of Cambridge Repository, 2020 BASE Show details 3 Linguistic diversity, multilingualism, and cognitive skills: A study of disadvantaged children in India Marinis, T; Alladi, S; Panda, M. - : MDPI AG, 2020. : Languages, 2020 BASE Show details 4 Multilingualism and multiliteracy in primary education in India: A discussion of some methodological challenges of an interdisciplinary research project ... Tsimpli, Ianthi; Mukhopadhyay, L; Treffers-Daller, J. - : Apollo - University of Cambridge Repository, 2019 BASE Show details 5 Basal insulin and cardiovascular and other outcomes in dysglycemia. Gerstein, H.C.; Bosch, J.; Dagenais, G.R.... In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012) BASE Show details 6 n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; Díaz, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C.; Rydén, L.E.; Yusuf, S. In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012) Abstract: BACKGROUND: The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown. METHODS: In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or diabetes to receive a 1-g capsule containing at least 900 mg (90% or more) of ethyl esters of n-3 fatty acids or placebo daily and to receive either insulin glargine or standard care. The primary outcome was death from cardiovascular causes. The results of the comparison between n-3 fatty acids and placebo are reported here. RESULTS: During a median follow up of 6.2 years, the incidence of the primary outcome was not significantly decreased among patients receiving n-3 fatty acids, as compared with those receiving placebo (574 patients [9.1%] vs. 581 patients [9.3%]; hazard ratio, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P=0.72). The use of n-3 fatty acids also had no significant effect on the rates of major vascular events (1034 patients [16.5%] vs. 1017 patients [16.3%]; hazard ratio, 1.01; 95% CI, 0.93 to 1.10; P=0.81), death from any cause (951 [15.1%] vs. 964 [15.4%]; hazard ratio, 0.98; 95% CI, 0.89 to 1.07; P=0.63), or death from arrhythmia (288 [4.6%] vs. 259 [4.1%]; hazard ratio, 1.10; 95% CI, 0.93 to 1.30; P=0.26). Triglyceride levels were reduced by 14.5 mg per deciliter (0.16 mmol per liter) more among patients receiving n-3 fatty acids than among those receiving placebo (P<0.001), without a significant effect on other lipids. Adverse effects were similar in the two groups. CONCLUSIONS: Daily supplementation with 1 g of n-3 fatty acids did not reduce the rate of cardiovascular events in patients at high risk for cardiovascular events. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.). Keyword: Aged; Cardiovascular Diseases/etiology; Cardiovascular Diseases/mortality; Cholesterol/blood; Combination; Diabetes Mellitus; Double-Blind Method; Drug Therapy; Fatty Acids; Female; Follow-Up Studies; Glucose Intolerance/complications; Glucose Intolerance/drug therapy; Humans; Hypoglycemic Agents/therapeutic use; Incidence; Insulin; Intention to Treat Analysis; Long-Acting/therapeutic use; Male; Middle Aged; Omega-3/therapeutic use; Proportional Hazards Models; Treatment Failure; Triglycerides/blood; Type 2/complications; Type 2/drug therapy URL: https://doi.org/10.1056/NEJMoa1203859 https://serval.unil.ch/notice/serval:BIB_83A3987D7CC1 BASE Hide details

Mobile view All Catalogues UB Frankfurt Linguistik 0 IDS Mannheim 0 OLC Linguistik 0 UB Frankfurt Retrokatalog 0 DNB Subject Category Language 0 Institut für Empirische Sprachwissenschaft 0 Leibniz-Centre General Linguistics (ZAS) 0 Bibliographies BLLDB 0 BDSL 0 IDS Bibliografie zur deutschen Grammatik 0 IDS Bibliografie zur Gesprächsforschung 0 IDS Konnektoren im Deutschen 0 IDS Präpositionen im Deutschen 0 IDS OBELEX meta 0 MPI-SHH Linguistics Collection 0 MPI for Psycholinguistics 0 Linked Open Data catalogues Annohub 0 Online resources Link directory 0 Journal directory 0 Database directory 0 Dictionary directory 0 Open access documents BASE 6 Linguistik-Repository 0 IDS Publikationsserver 0 Online dissertations 0 Language Description Heritage 0